Spansa Pharmaceuticals Private Limited, a active private limited company, was established on 03 September 2012 in Patna, Bihar, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24232BR2012PTC019175. Registered under ROC Roc Patna. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Ram Gopal Jayaswal (Director), Anuj Kedia (Director), Ayush Kumar Kediya (Director). Past directors included Ram Gopal Jayaswal, Anuj Kedia, Niraj Kumar. It holds ₹2.33 Cr open charges and no settled loans. Its latest AGM occurred on 27 September 2025, with the balance sheet filed on 31 March 2025. It is based at Ground Floor And First Floor, Nc-4B, Nandan Bhawan Gayatri Mandir Road, Kankarbagh, Patna, Bihar, 800020.
U24232BR2012PTC019175
019175
03 September 2012
₹0.10 M
₹0.10 M
Roc Patna
Unlisted
Active
Explore comprehensive insights into Spansa Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ram Gopal Jayaswal | Director | 27 Jul 2021 | Current |
| Anuj Kedia | Director | 29 Oct 2018 | Current |
| Ayush Kumar Kediya | Director | 03 Sep 2012 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 31 Oct 2021 | Past |
| Pramod Abcsdd | Additional Director | 28 Sep 2019 | Past |
| Pramod Abcsdd | Director | 01 Sep 2015 | Past |
| Pramod Abcsdd | Director | 10 Jun 2013 | Past |
| Pramod Abcsdd | Director | 02 Jan 2017 | Past |
| Pramod Abcsdd | Additional Director | 26 Sep 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Spansa Pharmaceuticals Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 25.47% increase. The company also saw a substantial improvement in profitability, with a 23.5% increase in profit. The company's net worth Soared by an impressive increase of 34.97%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Spansa Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹23,342,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Nov 2024 | Hdfc Bank Limited | ₹3.60 M | Open |
| 21 Aug 2023 | Hdfc Bank Limited | ₹1.70 M | Open |
| 23 Jul 2021 | Hdfc Bank Limited | ₹3.04 M | Open |
| 31 Jan 2019 | Hdfc Bank Limited | ₹1.50 Cr | Open |
Explore comprehensive loan charge details -
Spansa Pharmaceuticals has a workforce of 0 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Spansa Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Spansa Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Spansa Pharmaceuticals Private Limited last Annual general meeting of members was held on 27 Sep 2025 as per latest MCA records. was documented.
Progress on Spansa Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Patna. was documented.
The activity A charge with Hdfc Bank Limited amounted to Rs. 3.60 M with Charge ID 101042782 was registered on 25 Nov 2024. was completed.
A charge with Hdfc Bank Limited of Rs. 15.00 M registered on 31 Jan 2019 with Charge ID 100242988 was modified on 25 Apr 2024. was recorded as a recent event.
A charge with Hdfc Bank Limited amounted to Rs. 1.70 M with Charge ID 100812247 was registered on 21 Aug 2023. was recorded as a recent event.
Ram Gopal Jayaswal was appointed as a Director was appointed as a Director on 27 Jul 2021 & has been associated with this company since 4 years 4 months . was recorded as a recent event.
The CIN of Spansa Pharmaceuticals Private Limited is U24232BR2012PTC019175.
Spansa Pharmaceuticals Private Limited is headquartered at Ground Floor And First Floor, Nc-4B, Nandan Bhawan Gayatri Mandir Road, Kankarbagh, Patna, Bihar, 800020.
Spansa Pharmaceuticals Private Limited was incorporated on 03 September 2012.
The current directors of Spansa Pharmaceuticals Private Limited are
The primary industry of Spansa Pharmaceuticals Private Limited is Trade.
Spansa Pharmaceuticals Private Limited is unlisted.
The authorized capital of Spansa Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Spansa Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX